STAT

SEPTEMBER 24, 2024

WASHINGTON — Senate health committee chair Bernie Sanders said major drug middlemen have agreed not to limit coverage of Novo Nordisk’s Ozempic and Wegovy if the company lowers the prices of the treatments. It’s Sanders’ latest move to pressure Novo to cut the prices of the blockbuster diabetes and obesity therapies. Novo has been blaming pharmacy benefit managers for the high list prices of its drugs, arguing that it needs to be able to pay rebates to the middlemen i

Diabetes 356

Diabetes Drug Pricing 356

PharmaVoice

SEPTEMBER 24, 2024

Alicia Zhou brings startup bona fides to the nonprofit Cancer Research Institute to promote defragmentation of the cancer research effort.

182

182

STAT

SEPTEMBER 24, 2024

STAT is co-publishing this article by Tradeoffs. Lisa Ann Trainor struggled to stay on top of schoolwork, hold a job or even perform basic tasks like laundry for six exhausting years. Then, in 2018, she finally found a drug that kept her ADHD in check.

Drug Pricing 354

Drug Pricing Drug Development 354

Pharmacy Is Right For Me

SEPTEMBER 24, 2024

Hi Future Pharmacists! My name is Tazche Turner and I am a fourth year PharmD Candidate at the University of North Carolina’s (UNC) Eshelman School of Pharmacy. My passions for science, business and service led me to pursue a career in pharmacy. Throughout pharmacy school, I immersed myself into numerous organizations and leadership positions to really explore all pharmacy has to offer, but the organization I found my pharmacy home in was the Student National Pharmaceutical Association (SNPhA).

Diabetes 130

Diabetes Immunity Immunization 130

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

SEPTEMBER 24, 2024

Many disabled people are not included in official U.S. data. This is because there is “ No Box to Check ” to indicate their particular disability on surveys from the U.S. Census Bureau and other federal agencies. The questions used to identify people with disabilities are missing millions. Two question sets are most often used to assess disability in U.S. federal surveys: the American Community Survey Six (ACS-6) or the Washington Group Short Set (WG-SS).

350

350

pharmaphorum

SEPTEMBER 24, 2024

After various twists and turns in the regulator path, Ipsen has secured EU approval for Kayfanda, its treatment for severe itching (pruritus) in patients with the rare liver disease Alagille syndrome (ALGS).Kayfanda (odevixibat) is labeled in the EU to treat cholestatic pruritus – itching caused by impaired bile formation or flow – in children aged six months and over with ALGS, a disease caused by a genetic mutation that leads to liver damage and jaundice.

Labelling 118

Labelling 118

BioPharma Dive

SEPTEMBER 24, 2024

CEO Lars Fruergaard Jørgensen told lawmakers the company would consider new talks with insurers about the list prices of Wegovy and Ozempic if they pledge to keep the medicines on their formularies.

Diabetes 110

Diabetes 110

STAT

SEPTEMBER 24, 2024

Generate:Biomedicines, a Flagship Pioneering company using artificial intelligence to create new medicines, announced today that it has struck a deal with Novartis to develop an undisclosed number of targets in various disease areas. With milestone payments, the company is eligible to receive over $1 billion, in addition to royalties. Novartis is paying Generate $65 million up front, which includes $15 million for an undisclosed amount of equity in the company.

Drug Development 318

Drug Development 318

Outsourcing Pharma

SEPTEMBER 24, 2024

The small molecule drug arimoclomol (Miplyffa) has got the green light from the U.S. Food and Drug Administration (FDA) for the treatment of the rare disease Niemann-Pick disease type C (NPC), which until now has lacked FDA-approved therapies.

105

105

STAT

SEPTEMBER 24, 2024

Amgen on Tuesday reported that a pair of antibody drugs it is developing as treatments for immune-mediated diseases succeeded in late-stage trials, but the therapies did not clearly beat existing competitors on the market. In the Phase 3 trials, dubbed Horizon and Mint, the California company tested therapies for eczema and myasthenia gravis, respectively.

Immunity 317

Immunity Immunization 317

Speaker: Joe Sharpe and James Carlson

Running a small business is no small feat. Payroll management, in particular, can be one of the most time-consuming and complex parts of that equation. Yet, businesses that crack the code on streamlining these processes often discover not just savings, but new avenues for growth. Our expert speakers will share actionable insights and real-world examples of how businesses have reduced overhead and improved payroll efficiency.

The Pharmacist

SEPTEMBER 24, 2024

Community pharmacies in England have been told to consider winding down their stocks of sub-dermal contraceptive implants, as supply routes are set to change. From 1 January 2025, GP practices will be able to order the sub dermal contraceptive implant (Nexplanon 68mg implant) directly, NHS England revealed last week in its primary care bulletin. This […] The post Pharmacies told to wind down stocks of contraceptive implant appeared first on The Pharmacist.

Community Pharmacies 104

Community Pharmacies 104

STAT

SEPTEMBER 24, 2024

This summer, the American Red Cross declared an emergency blood shortage in the U.S. There’s a seasonal pattern to blood donations, which often dip over the summer and during the winter holidays. But experts also say that climate change disrupts the national blood supply, with extreme heat and worsening storms in certain regions keeping people away from blood banks.

302

302

Pharmaceutical Technology

SEPTEMBER 24, 2024

Coverage for its long-acting insulin, Levamir, dropped from 90% to about 35% when the company dropped its list price by 65%.

120

120

STAT

SEPTEMBER 24, 2024

In the latest slap at a pharmaceutical company by a local government, the city of Baltimore has filed a lawsuit accusing Biogen of striking an “unlawful” scheme with the largest pharmacy benefit managers to block generic competition of a best-selling multiple sclerosis treatment. The effort allegedly originated as Biogen planned to fend off generic companies that hoped to sell lower-cost alternatives to Tecfidera which, several years ago, had been a franchise product and generated

Pharmaceutical Companies 295

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 295

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

SEPTEMBER 24, 2024

Roche launches 12 in one test for respiratory virus, using its 'revolutionary' TAGS tech, that can be used in regular clinical labs

109

109

STAT

SEPTEMBER 24, 2024

What was that mosquito thinking as the six needles of its proboscis mouth bit into my mother’s skin? Had it taken a long, unplanned journey in a bag as a tourist traveled north from a tropical Caribbean island? Or was it an old-time New York mosquito that had feasted the night before on the sweaty skin of a feverish traveler from the south? My mother would remain incredulous at her bad luck: Why did this mosquito choose her arm to snack upon?

291

291

pharmaphorum

SEPTEMBER 24, 2024

Discover how the Within3 Insights Management Platform can support smart decision-making with its innovative features and capabilities. Learn more about this powerful solution spotlight.

95

95

STAT

SEPTEMBER 24, 2024

Shares of Regeneron fell 5% yesterday after the company’s effort to block Amgen from launching a biosimilar version of its blockbuster eye drug Eylea hit a legal roadblock.  The judge overseeing a patent infringement case denied Regeneron’s request for a temporary injunction that would have barred Amgen from immediately selling its Eylea copy, called Pavblu.

Biosimilars 283

Biosimilars 283

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Outsourcing Pharma

SEPTEMBER 24, 2024

The US biotechâs neurological drug candidate showed a reduction in disease progression of at least 50% and the company will now file with the FDA.

105

105

STAT

SEPTEMBER 24, 2024

Good morning, lots of news today so we’ll get straight into it. The need-to-know this morning Bluebird Bio said it will lay off 25% of its workforce as part of a restructuring plan needed to reduce the company’s cash operating expenses by 20%. Bluebird has struggled to generate revenue from three approved gene therapies, including Lyfgenia for sickle cell disease.

Drug Pricing 277

Drug Pricing Drug Development 277

The Pharmacist

SEPTEMBER 24, 2024

Childhood vaccine uptake in England fell again across all 14 measures tracked by the NHS in the past year, the annual report has shown. No vaccines met the 95% target for coverage, the data for 2023/24 shows and particular concerns were raised about uptake of key vaccines by five years of age. The further declines in uptake […] The post Childhood vaccine uptake in England declines further despite disease outbreaks appeared first on The Pharmacist.

Vaccines 92

Vaccines 92

STAT

SEPTEMBER 24, 2024

Gene therapy company Bluebird Bio on Tuesday announced a 25% reduction of its workforce as part of a restructuring meant to save the money as it seeks to market its expensive but potentially life-saving treatments for sickle cell disease and other disorders. The company, which has secured approval from the U.S. Food and Drug Administration for treatments including the sickle-cell gene therapy Lyfgenia, has not yet seen the financial payoff from its scientific breakthroughs — and it says i

267

267

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

SEPTEMBER 24, 2024

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.Data from the PHOENYCS GO study in moderate to severe SLE patients isn't available yet, but the partners say dapirolizumab pegol achieved a "clinical improvement" in the primary and secondary endpoints, including measures of disease activity and flares.

90

90

STAT

SEPTEMBER 24, 2024

Top of the morning to you, and a fine one it is, despite the dreary gray skies hovering over the Pharmalot campus. We are doing our best to maintain sunny spirits, though, because once again, we recall some helpful wisdom from the Morning Mayor, who taught us that “every new day should be unwrapped like a precious gift.” Words to live by, yes?

Biosimilars 263

Biosimilars 263

Pharmaceutical Technology

SEPTEMBER 24, 2024

The EMA CHMP has recommended granting approval for AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis (EGPA).

104

104

STAT

SEPTEMBER 24, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it  delivered in your inbox every Tuesday and Thursday. Texas AG reaches settlement in health AI probe In other legal news, the Texas Attorney General has reached a settlement with a Dallas health AI company that the government charged with making false claims about its products’ accuracy and safety before deploying them at Texas

Hospitals 224

Hospitals 224

Pharmaceutical Technology

SEPTEMBER 24, 2024

The EC has granted marketing authorisation to LEO Pharma’s Anzupgo cream for treating adults with moderate to severe chronic hand eczema.

98

98

PioneerRx

SEPTEMBER 24, 2024

It's the people who make the job. From both sides of the pharmacy counter, your patients and pharmacy staff set the tone and tempo for your pharmacy operations.

85

85

Pharmaceutical Technology

SEPTEMBER 24, 2024

Telix has paid an upfront cost of $230m to acquire 31 licenced radiopharmacies from RLS located across the US.

104

104

pharmaphorum

SEPTEMBER 24, 2024

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has put out a call for developers of artificial intelligence as a medical device (AIaMD) technology to join its new regulatory pilot.

73

73

Pharmaceutical Technology

SEPTEMBER 24, 2024

Discover the leading Pharmaceutical Packaging Companies, Suppliers & Solutions. Download the free Buyer's Guide today for full details.

Packaging 88

Packaging 88

BioPharma Dive

SEPTEMBER 24, 2024

Metsera revealed Phase 1 data it claims could support a weight-loss medicine that's administered monthly. Elsewhere, Sanofi invested in a struggling biotech and shares of two Duchenne drug developers climbed.

Drug Development 67

Drug Development 67